The limited, or absent capacity of rhPRG4 to slow down HCC cell proliferation in vitro is in apparent contrast with the strong positive correlation we observed between PRG4 expression and patients’ overall survival rates. The gene discussed is PRG4; the disease is hepatocellular carcinoma.